14 Recruiting Trials

Clinical Trials
for Alzheimer's in Louisiana

14 clinical trials for Alzheimer's are currently recruiting participants at study sites in Louisiana. Study-related care is provided at no cost.

14
Recruiting trials
11
Study sites
6
Cities
11
Industry-sponsored
5
Phase 2
7
Phase 3

Alzheimer's clinical trials in Louisiana: what to expect

Alzheimer's trials now span the whole course of the disease. Prevention studies enroll people with normal memory who have early signs of amyloid in the brain; treatment studies enroll people with mild cognitive impairment or early Alzheimer's and test the next generation of antibodies, tau-targeting drugs and combinations; and symptom studies address agitation, sleep and depression in later stages. Alongside drugs there are trials of exercise, cognitive training, blood tests for diagnosis and support programs for care partners.

In Louisiana, recruiting alzheimer's studies are concentrated in Marrero, Baton Rouge, Metairie and Alexandria, with sites in 2 other cities. 11 of the 14 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who Alzheimer's trials usually look for

Most drug trials enroll ages 50 to 85 and define a stage with a memory test score range, then confirm Alzheimer's with an amyloid PET scan, a spinal fluid test or, increasingly, a blood test, all done by the study. Nearly every trial requires a study partner: someone who knows you well, attends visits and answers questions about daily life. Common exclusions are another cause of memory loss, a recent stroke and, for antibody trials, some blood thinners or MRI findings. Prevention trials enroll people with no symptoms at all.

What taking part involves

Screening is longer than for most conditions, often several visits over a few weeks with memory testing, an MRI and an amyloid test. Antibody trials then involve an infusion or injection every two to four weeks, regular safety MRIs and visits for eighteen months to four years, with an extension in which everyone receives the drug. Lifestyle trials involve classes or coaching for six to twenty-four months. All study care is free and travel is usually reimbursed for you and your partner.

Questions worth asking the study team

Whether you will be told your amyloid or genetic results; what the MRI safety monitoring involves; how much time the study partner must give; whether there is an extension after the placebo period; and what happens if memory worsens during the study.

Showing 14 of 14 recruiting Alzheimer's trials in Louisiana

ACP-204 in Adults With Alzheimer's Disease Psychosis
PHASE2 Chandler, Arizona +4 sites NCT06159673
This trial is looking for adults aged 55 to 95 who have Alzheimer's disease psychosis. Participants will receive either ACP-204 or a placebo for six weeks, with follow-up visits to check on their health afterwards.
Recruiting
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
PHASE3 Birmingham, Alabama +4 sites NCT07177352
This trial is looking for individuals who may qualify for Alzheimer's disease research studies. Participants will be assessed to see if they can join related interventional studies.
Recruiting
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
PHASE3 Homewood, Alabama +4 sites NCT05980949
This trial is looking for people who have completed previous studies on KarXT for Alzheimer's-related psychosis. Participants will take KarXT for a year to help researchers understand its long-term safety and tolerability.
Recruiting
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
PHASE3 Chandler, Arizona +4 sites NCT06126224
This trial is looking for men and women aged 55 to 90 who have Alzheimer's disease along with symptoms like hallucinations or delusions. They need to have a stable living situation and a trusted person who sees them regularly. However, people with certain other mental health conditions or serious medical issues will not be eligible to participate.
Recruiting
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
PHASE3 Birmingham, Alabama +4 sites NCT07169578
This trial is looking for people with early Alzheimer's disease symptoms. Participants will take part in tests to evaluate their memory and cognitive abilities while receiving treatment.
Recruiting
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
PHASE2 Phoenix, Arizona +4 sites NCT06887192
This trial is looking for men and women aged 55 to 90 who have Alzheimer's disease and are experiencing symptoms like hallucinations or delusions. They need to have been living in the same place for at least six weeks and have a support person who can help track their health. However, it’s important to note that people who are seriously ill, have other major medical issues, or have substance abuse problems can't participate.
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
PHASE3 Scottsdale, Arizona +4 sites NCT07011732
This trial is looking for adults with Alzheimer's disease who experience agitation. Participants will take the study medication and have regular visits to assess their condition.
Recruiting
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
PHASE2 Phoenix, Arizona +4 sites NCT06847321
This trial is looking for people with mild to moderate Alzheimer's who also have a specific infection. Participants will take a daily capsule and attend study visits over 64 weeks.
Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
PHASE2 Homewood, Alabama +4 sites NCT06808984
This trial is looking for people with Alzheimer's disease who experience agitation. Participants will take a medication called BMS-986368 and help researchers understand its effects.
Recruiting
Clinical Trial on Agitation in Alzheimer's Dementia
PHASE2 Maitland, Florida +4 sites NCT05543681
This trial is looking for people with Alzheimer's who experience agitation. Participants will take a THC-based medication twice a day and will be monitored for its effects.
Recruiting
Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Impairment (RAATE-MCI)
NA Baton Rouge, Louisiana NCT04956549
This trial is looking for African American adults aged 60 and older without regular exercise experience. Participants will take part in an exercise program over the course of 52 weeks.
Recruiting
Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)"
NA Baton Rouge, Louisiana NCT03890861
This trial is looking for older African American adults who want to see if an exercise program can help reduce the risk of Alzheimer's disease. Participants will join a group exercise program and attend regular sessions.
Recruiting
Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition
NA Baton Rouge, Louisiana NCT07265323
This trial is looking for adults with Alzheimer's Disease to see if weekly insulin injections can help with their thinking skills and how their body uses sugar. Participants will receive insulin weekly for 6 months and complete some memory tests.
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
PHASE3 Phoenix, Arizona +4 sites NCT07602582
This trial is looking for people who have previously participated in a related study and who want to see if they benefit from yearly doses of donanemab. Participants will attend up to 6 visits during the study, which lasts up to 2.5 years.
Recruiting

Where the Alzheimer's studies are in Louisiana

  • Local Institution - 1114, Marrero2 trials
  • Pennington Biomedical Research Center, Baton Rouge2 trials
  • Tandem Clinical Research, LLC, Marrero2 trials
  • Care Access - Lake Charles (Bayou Pines), Lake Charles1 trial
  • Clinical Site, Alexandria1 trial
  • Grace Research, LLC, Shreveport1 trial

Counts are recruiting studies listing at least one site in Louisiana, from ClinicalTrials.gov, refreshed every two days.

Alzheimer's clinical trials in Louisiana: common questions

How many Alzheimer's clinical trials are recruiting in Louisiana?
TrialFinder currently lists 14 recruiting Alzheimer's clinical trials with study sites in Louisiana. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Alzheimer's clinical trials located in Louisiana?
Study sites for the Alzheimer's trials listed on this page include Baton Rouge. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Alzheimer's clinical trial in Louisiana?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Alzheimer's trials in Louisiana also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Alzheimer's clinical trial in Louisiana?
Each study sets its own criteria based on age, Alzheimer's diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Do I need an Alzheimer's diagnosis to join a trial?
No. Prevention trials enroll people with normal memory and test them for early amyloid, and many treatment trials accept people with memory concerns who have not been formally diagnosed, then confirm the diagnosis as part of screening.
What is a study partner?
A family member or close friend who attends visits with you and answers questions about memory and daily activities. Nearly every Alzheimer's trial requires one, and their time is usually reimbursed too.
Will I learn my amyloid or APOE results?
Many trials now disclose amyloid status, since it decides eligibility, and explain what it means. Genetic results are disclosed in some trials and not others; ask before you consent.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Alzheimer's trials near you in Louisiana.

Get Matched — Free
No insurance required

Alzheimer's disease trials test amyloid-clearing antibodies, tau inhibitors, lifestyle interventions, and early-detection biomarkers for dementia prevention and treatment.

All Alzheimer's trials →